Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.
2.

Schizophrenia, obesity, and antipsychotic medications: what can we do?

Citrome L, Vreeland B.

Postgrad Med. 2008 Jul;120(2):18-33. doi: 10.3810/pgm.2008.07.1786. Review.

PMID:
18654065
3.

Schizophrenia and obesity: impact of antipsychotic medications.

Wirshing DA.

J Clin Psychiatry. 2004;65 Suppl 18:13-26. Review.

4.

Management of schizophrenia with obesity, metabolic, and endocrinological disorders.

Monteleone P, Martiadis V, Maj M.

Psychiatr Clin North Am. 2009 Dec;32(4):775-94. doi: 10.1016/j.psc.2009.08.003. Review.

PMID:
19944883
5.

[Metabolic risk during antipsychotic treatment in patients with schizophrenia].

Rzewuska M.

Psychiatr Pol. 2007 Jul-Aug;41(4):457-72. Review. Polish.

PMID:
18046977
6.

Weight gain with atypical antipsychotics: evidence and insights.

Henderson DC.

J Clin Psychiatry. 2007;68 Suppl 12:18-26. Review.

7.

Antipsychotic induced weight gain in schizophrenia:mechanisms and management.

Rege S.

Aust N Z J Psychiatry. 2008 May;42(5):369-81. doi: 10.1080/00048670801961123. Review.

PMID:
18473255
8.

Metabolic risk during antipsychotic treatment.

Newcomer JW.

Clin Ther. 2004 Dec;26(12):1936-46. Review.

PMID:
15823759
9.
10.

Management of weight gain associated with antipsychotics.

Birt J.

Ann Clin Psychiatry. 2003 Mar;15(1):49-58. Review.

PMID:
12839432
11.

Switching in the era of atypical antipsychotics. An updated review.

Weiden PJ.

Postgrad Med. 2006 Sep;Spec No:27-44. Review.

PMID:
17128659
12.
13.

The clinical implications of weight gain in schizophrenia.

Kurzthaler I, Fleischhacker WW.

J Clin Psychiatry. 2001;62 Suppl 7:32-7. Review.

14.

Reversal of antipsychotic-associated weight gain.

O'Keefe CD, Noordsy DL, Liss TB, Weiss H.

J Clin Psychiatry. 2003 Aug;64(8):907-12.

PMID:
12927005
15.

Weight gain associated with use of psychotropic medications.

Sachs GS, Guille C.

J Clin Psychiatry. 1999;60 Suppl 21:16-9. Review.

16.

Weight gain from novel antipsychotic drugs: need for action.

Green AI, Patel JK, Goisman RM, Allison DB, Blackburn G.

Gen Hosp Psychiatry. 2000 Jul-Aug;22(4):224-35. Review.

PMID:
10936629
17.

Metabolic risks and effects of atypical antipsychotic treatment.

Haupt DW, Kane JM.

J Clin Psychiatry. 2007 Oct;68(10):e24.

18.

Strategies for dosing and switching antipsychotics for optimal clinical management.

Buckley PF, Correll CU.

J Clin Psychiatry. 2008;69 Suppl 1:4-17. Review.

19.
20.

[Atypical antipsychotic induced weight gain and metabolic disorders].

Rojas G P, Poblete A C, Orellana G X, Rouliez A K, Liberman G C.

Rev Med Chil. 2009 Jan;137(1):106-14. doi: /S0034-98872009000100017. Epub 2009 Apr 23. Review. Spanish.

Supplemental Content

Support Center